| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8631985 | Journal of Diabetes and its Complications | 2018 | 18 Pages |
Abstract
Increased levels of hsCRP and ICAM1 were found to be significant biomarkers for early reduced anatomic response to anti-VEGF treatment. Cases with higher serum levels of such factors had increased CFT values, despite treatment, suggesting inner blood-retinal barrier breakdown that is not adequately responsive to anti-VEGF monotherapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Pedro Brito, Jorge Costa, Nuno Gomes, Sandra Costa, Jorge Correia-Pinto, Rufino Silva,